McNeil Consumer Healthcare, a division of pharmaceutical company, Johnson & Johnson, announced on Monday that it is recalling from retailers and wholesalers approximately 2.5 million packages of Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps.
The company said that it issued the recall as a precaution, stemming from the discovery of higher-than-expected levels of a compound called chlorpheniramine ammonio acetate (CPAA), which is formed by the combination of two of the product’s ingredients. McNeil made a point to note that the presence of CPAA has not been associated with any safety concerns or health problems.
Several of McNeil’s plants were the subject of an official FDA investigation and were ultimately cited for manufacturing problems. In fact, in April 2010, the company’s Fort Washington plant was ultimately shutdown as a result of the problems. However, products made before the plant’s closing are still being recalled. This week’s recall marks the fifth this year for McNeil.
